Baystreet.ca News On ONCY

• The $537B Precision Pivot: Why Molecular Monitoring is the New Oncology Standard - 11:36 AM 1/8/2026
• Targeted Precision: Rare Disease Assets Attract Record Regulatory Momentum - 9:54 AM 1/7/2026
• Novel Modalities Drive $668B Precision Oncology Expansion - 11:34 AM 1/2/2026
• Pivotal Cancer Trials Gain Momentum as Regulatory Clarity Emerges - 11:08 AM 12/16/2025
• Platform Oncology Technologies Drive Multi-Indication Treatment Expansion - 9:35 AM 12/12/2025
• Oncology Investment Surge Hits $1.3B as Private Sector Fills Public Funding Gaps - 11:29 AM 9/16/2025
• FDA Accelerates Cancer Drug Pipeline as Market Momentum Surges Past $400B - 9:28 AM 9/8/2025
• FDA Fast-Track Cancer Treatments Drive Market Surge as Innovations Accelerate - 9:33 AM 9/2/2025